LifeStance Health Group (LFST)
(Delayed Data from NSDQ)
$6.74 USD
0.00 (0.00%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $6.74 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Balance Sheet
Fiscal Year End for LifeStance Health Group, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 79 | 109 | 148 | 19 | 3 |
Receivables | 125 | 101 | 76 | 44 | 19 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 22 | 24 | 42 | 14 | 5 |
Total Current Assets | 226 | 233 | 267 | 76 | 27 |
Net Property & Equipment | 188 | 194 | 152 | 59 | 22 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,514 | 1,536 | 1,505 | 1,431 | 230 |
Deposits & Other Assets | 11 | 11 | 3 | 3 | 1 |
Total Assets | 2,110 | 2,174 | 1,927 | 1,570 | 281 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7 | 12 | 14 | 8 | 4 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 137 | 106 | 87 | 53 | 28 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 12 | 19 | 16 | 16 | 23 |
Total Current Liabilities | 203 | 176 | 117 | 76 | 55 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 16 | 39 | 54 | 81 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 280 | 225 | 157 | 363 | 79 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 3 | 54 | 52 | 312 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 681 | 655 | 382 | 572 | 447 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 4 | 4 | 4 | 1,010 | 0 |
Capital Surplus | 2,184 | 2,084 | 1,898 | 1 | 0 |
Retained Earnings | -761 | -573 | -357 | -13 | -166 |
Other Equity | 2 | 3 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1,429 | 1,519 | 1,545 | 998 | -166 |
Total Liabilities & Shareholder's Equity | 2,110 | 2,174 | 1,927 | 1,570 | 281 |
Total Common Equity | 1,429 | 1,519 | 1,545 | 998 | -166 |
Shares Outstanding | 378.60 | 375.90 | 374.10 | NA | NA |
Book Value Per Share | 3.77 | 4.04 | 4.13 | -0.01 | 0.00 |
Fiscal Year End for LifeStance Health Group, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 87 | 49 | 79 | 43 | 80 |
Receivables | 167 | 176 | 125 | 150 | 122 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 24 | 19 | 22 | 72 | 36 |
Total Current Assets | 278 | 244 | 226 | 264 | 238 |
Net Property & Equipment | 176 | 182 | 188 | 190 | 193 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,493 | 1,502 | 1,514 | 1,527 | 1,537 |
Deposits & Other Assets | 12 | 12 | 11 | 13 | 11 |
Total Assets | 2,119 | 2,106 | 2,110 | 2,175 | 2,171 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 10 | 12 | 7 | 10 | 8 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 161 | 138 | 137 | 175 | 115 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 7 | 8 | 12 | 12 | 14 |
Total Current Liabilities | 228 | 207 | 203 | 241 | 181 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 16 | 16 | 16 | 38 | 38 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 279 | 280 | 280 | 248 | 249 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 1 | 1 | 3 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 689 | 677 | 681 | 720 | 676 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 4 | 4 | 4 | 4 | 4 |
Capital Surplus | 2,229 | 2,204 | 2,184 | 2,163 | 2,141 |
Retained Earnings | -805 | -782 | -761 | -716 | -654 |
Other Equity | 3 | 3 | 2 | 4 | 4 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1,430 | 1,429 | 1,429 | 1,455 | 1,495 |
Total Liabilities & Shareholder's Equity | 2,119 | 2,106 | 2,110 | 2,175 | 2,171 |
Total Common Equity | 1,430 | 1,429 | 1,429 | 1,455 | 1,495 |
Shares Outstanding | 382.20 | 382.20 | 378.60 | 378.00 | 376.70 |
Book Value Per Share | 3.74 | 3.74 | 3.77 | 3.85 | 3.97 |